首页> 外文期刊>Carbohydrate research >The pattern of glycosyl-and sulfotransferase activities in cancer cell lines:a predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans
【24h】

The pattern of glycosyl-and sulfotransferase activities in cancer cell lines:a predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans

机译:癌细胞系中糖基和磺基转移酶活性的模式:单个癌症相关的独特碳水化合物结构的预测因子,用于特征性聚糖的结构鉴定

获取原文
获取原文并翻译 | 示例
           

摘要

Carbohydrate chains of cancer glycoprotein antigens contain major outer changes dictated by tissue-specific regulation of glycosyltransferase genes,the availability of sugar nucleotides,and competition between enzymes for acceptor intermediates during glycan elongation.However,it is evident from recent studies with recombinant mucin probes that the final glycosylation profiles of mucin glycoproteins are mainly determined by the cellular repertoire of glycosyltransferases.Hence,we examined various cancer cell lines for the levels of fucosyl-,beta-galactosyl,beta-N-acetylgalactosaminyl-,sialyl-,and sulfotransferase activities that generate the outer ends of the oligosaccharide chains.We have identified glycosyltransferases activities at the levels that would give rise to O-glycan chains as reported by others in breast cancer celllines,T47D,ZR75-1,MCF-7,and MDA-MB-231.Most breast cancer cells express Gal-3-O-sulfotransferase specific for T-hapten Gal beta1->3GalNAco alpha-,whereas the enzyme from colon cancer cells exhibits a vast preference for the Gal beta1,4GlcNAc terminal unit in O-glycans.We also studied ovarian cancer cells SW626 and PA-1 and hepatic cancer cells HepG_2.Our studies show that alha1,2-L-fucosyl-T,alpha(2,3)sialyl-T,and 3-O-Sulfo-T capable of acting on the mucin core 2 tetrasaccharide,Gal beta1,4GlcNAc beta1,6(Gal beta1,3)GalNAc alpha-,can also act on the Globo H antigen backbone,Gal beta1,3GalNAc beta1,3Gal alpha-,suggesting the existence of unique carbohydrate moieties in certain cancer-associated glycolipids.Briefly,our study indicates the following:(i)3'-Sulfo-T-hapten has an apparent relationship to the tumorigenic potential of breast cancer cells;(ii)the 3'-sulfo Lewis~x,the 3-O-sulfo-Globo unit,and the 3-fucosylchitobiose core could be uniquely associated with colon cancer cells;(iii)synthesis of a polylactosamine chain and T-hapten are favorable in ovarian cancer cells due to negligible sialyltrans-ferase activities;and (iv)a 6'-sialyl LacNAc unit and 3'-sialyl T-hapten appear to be prevalent structures in hepatic cancer cell glycans.Thus,it is apparent that different cancer cells are expressing unique glycan epitopes,which could be novel targets for cancer diagnosis and treatment.
机译:癌症糖蛋白抗原的糖链包含主要的外部变化,这些变化是由糖基转移酶基因的组织特异性调节,糖核苷酸的可用性以及聚糖延伸过程中受体中间体的酶之间的竞争所决定的。然而,从最近对重组粘蛋白探针的研究中可以明显看出:黏蛋白糖蛋白的最终糖基化概况主要取决于糖基转移酶的细胞组成。因此,我们检查了各种癌细胞系中的岩藻糖基,β-半乳糖基,β-N-乙酰基半乳糖胺基,唾液酸基和磺基转移酶活性,我们已经鉴定了糖基转移酶的活性水平,该水平会引起乳腺癌细胞系T47D,ZR75-1,MCF-7和MDA-MB- 231.大多数乳腺癌细胞表达特异于T-半抗原Gal beta1-> 3GalNAco alpha-的Gal-3-O-磺基转移酶,而enz结肠癌细胞中的yme在O-聚糖中对Gal beta1,4GlcNAc末端单元表现出极大的偏爱。我们还研究了卵巢癌细胞SW626和PA-1和肝癌细胞HepG_2。我们的研究表明alha1,2-L-岩藻糖基-T,alpha(2,3)sialyl-T和3-O-Sulfo-T能够作用于粘蛋白核心2四糖,Gal beta1,4GlcNAc beta1,6(Gal beta1,3)GalNAc alpha-,作用于Globo H抗原主链Gal beta1,3GalNAc beta1,3Gal alpha-,暗示某些癌症相关糖脂中存在独特的碳水化合物部分。简而言之,我们的研究表明:(i)3'-Sulfo-T-半抗原与乳腺癌细胞的致癌性有明显的关系;(ii)3'-磺基Lewis_x,3-O-磺基-球蛋白单元和3-岩藻糖基壳二糖核心可能与结肠癌细胞具有独特的联系(iii)由于唾液酸转移酶活性可忽略,因此在卵巢癌细胞中合成聚乳糖胺链和T-半抗原是有利的;以及(iv)6'-唾液酸LacNA c单位和3'-唾液酸T-半抗原似乎是肝癌细胞聚糖中的普遍结构。因此,很明显,不同的癌细胞表达独特的聚糖表位,这可能是癌症诊断和治疗的新靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号